IN VITRO TEST SYSTEMS FOR EVALUATING CHEMOTHERAPIES AGAINST HIV

NIH GUIDE, Volume 23, Number 33, September 16, 1994



RFP AVAILABLE:  NIH-NIAID-DAIDS-95-19



P.T.





Keywords:



National Institute of Allergy and Infectious Diseases



The Developmental Therapeutics Branch, Basic Research and Development

Program, Division of AIDS of the National Institute of Allergy and

Infectious Diseases (NIAID), NIH has a requirement for in vitro test

systems to evaluate chemotherapies against HIV.  The Contractor will be

required to do the following with compounds provided by the Government:

evaluate potential therapeutic agents in cell-based in vitro assays for

anti-HIV efficacy and cytotoxicity; analyze the data generated in

antiviral and cytotoxicity assays; and provide an assessment of the

experimental data.  The RFP contains mandatory qualification criteria

that excludes pharmaceutical companies from participating as an offeror

or subcontractor.  A pharmaceutical company is defined as an

organization which sells drugs or other therapeutic agents for profit.



This announcement is a recompetition for two current contracts (Emory

University N01-AI-05078 and IIT Research Institute N01-AI-05077).  It

is anticipated that there will be two awards.  The issuance of the RFP

will be on or about September 16, 1994 and proposals will be due by COB

on or about December 9, 1994.  It is anticipated that two level-of-

effort type cost-reimbursement contracts will be awarded and that the

period of performance for this contract will be five years.  The

approximate start date of the contract will be on or about July 9,

1995.



INQUIRIES



A short-form version of the RFP will be available, for informational

purposes, which includes only the background information, the full

Statement of Work, and Evaluation Criteria.  There is sufficient

information in this document to enable prospective offerors to

determine if they have the expertise/capability to meet the

Government's requirements.  A full-text version will also be available,

which includes all the necessary information, business forms, etc., in

order to submit a proposal.  Request the short-form RFP first, then the

full-text version of the RFP.  FAX requests are acceptable, but written

requests containing two self-addressed mailing labels are preferred.



Requests for the RFP are to be directed to:



Mr. Ross Kelley

Contract Management Branch

National Institute of Allergy and Infectious Diseases

Solar Building, Room 3C07

6003 Executive Boulevard, MSC 7610

Bethesda, MD  20892-7610

Telephone:  (301) 402-2234

FAX:  (301) 402-0972)



This advertisement does not commit the Government to award a contract.

No collect calls will be accepted.



.


Return to 1994 Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.